Both in Pharmaceuticals
First Tracks Biotherapeutics vs Xeris Biopharma Holdings
Over the past year TRAX returned +23.7% and XERS returned +43.8%; their daily moves had a correlation of 0.14.
TRAX +23.7% XERS +43.8%Growth of $1, one year, split-adjusted
| Metric | TRAX | XERS |
|---|---|---|
| Price | $45.08 | $10.71 |
| Market cap | $1.89B | $1.95B |
| Today | −0.32% | −0.37% |
| 1 month | +32.9% | +15.8% |
| 6 months | — | +70.5% |
| Year to date | — | +36.4% |
| 1 year | — | +11.3% |
| Revenue growth (YoY) | — | +28.7% |
| Gross margin | — | 86.4% |
| Net margin | — | −33.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.8× |
| Net cash | $168.0M | -$130.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 53.0% |
| Short % of float | 21.3% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).